Evidence for global health

Jha, Prabhat; Lavery, James V.
May 2004
CMAJ: Canadian Medical Association Journal;5/25/2004, Vol. 170 Issue 11, p1687
Academic Journal
Discusses research being done on the paucity of randomized controlled trials (RCT) in addressing major global diseases. Reference to a study by P.A. Rochon et al., published in the May 25, 2004 issue of the "Canadian Medical Association Journal"; Lack of evidence from RCT being directed to global diseases; Barriers in the lack of studies in developing countries.


Related Articles

  • Relation between randomized controlled trials published in leading general medical journals and the global burden of disease. Rochon, Paula A.; Mashari, Azad; Cohen, Ariel; Misra, Anjali; Laxer, Dara; Streiner, David L.; Dergal, Julie M.; Clark, Jocalyn R.; Gold, Jennifer; Binns, Malcolm A. // CMAJ: Canadian Medical Association Journal;5/25/2004, Vol. 170 Issue 11, p1673 

    Background: More than two-thirds of the world's population live in low-income countries, where health priorities are different from those of people living in more affluent parts of the world. We evaluated the relation between the global burden of dis-ease and conditions or diseases studied...

  • Lessons Learned from Large Cardiovascular Trials. Rumboldt, Zvonko // Medicinski Arhiv;2007 Supplement, Vol. 61 Issue 2, p38 

    Controlled clinical trial methodology includes unbiased data gathering, subject to statistical analysis, eliminating subjective and environmental influences on the results. These studies compare treatments in patients minimizing or equalizing all variables except the intervention (mostly a drug)...

  • Improving the Precision of Clinical Trials. Mosteller, Frederick // American Journal of Public Health;May82, Vol. 72 Issue 5, p430 

    The article reflects on improvement relative to clinical research and trials. It believes that the use of severity of illness score or the Acute Physiology Score will help in developing and improving the precision of clinical trials since the increase in death rates is one factor that minimizes...

  • Registering clinical trials is necessary for ethical,scientific and economic reasons. Antes, Gerd // Bulletin of the World Health Organization;May2004, Vol. 82 Issue 5, p321 

    Editorial. Discusses the ethical, scientific and economic reasons for registering clinical trials. Importance of public access to trial information; Publicly available web sites developed by the United States National Institutes of Health to facilitate searching for clinical trials; Efforts of...

  • Improving the Reported Quality of Nonrandomized Evaluations of Behavioral and Public Health Interventions: The TREND Statement. Des Jarlais, Don C.; Lyles, Cynthia; Crepaz, Nicole // American Journal of Public Health;Mar2004, Vol. 94 Issue 3, p361 

    Developing an evidence base for making public health decisions will require using data from evaluation studies with randomized and nonrandomized designs. Assessing individual studies and using studies in quantitative research syntheses require transparent reporting of the study, with sufficient...

  • Evidence-Based Public Health: Moving Beyond Randomized Trials. Victora, Cesar G.; Habicht, Jean-Pierre; Bryce, Jennifer // American Journal of Public Health;Mar2004, Vol. 94 Issue 3, p400 

    Randomized controlled trials (RCTs) are essential for evaluating the efficacy of clinical interventions, where the causal chain between the agent and the outcome is relatively short and simple and where results may be safely extrapolated to other settings. However, causal chains in public health...

  • Design and Analysis of Group-Randomized Trials: A Review of Recent Methodoligical Developments. Murray, David M.; Blitstein, Jonathan L.; Varnell, Sherri P. // American Journal of Public Health;Mar2004, Vol. 94 Issue 3, p423 

    We review recent developments in the design and analysis of group-randomized trials (GRTs). Regarding design, we summarize developments in estimates of intraclass correlation, power analysis, matched designs, designs involving one group per condition, and designs in which individuals are...

  • Methods for Specifying the Target Difference in a Randomised Controlled Trial: The Difference ELicitation in TriAls (DELTA) Systematic Review. Hislop, Jenni; Adewuyi, Temitope E.; Vale, Luke D.; Harrild, Kirsten; Fraser, Cynthia; Gurung, Tara; Altman, Douglas G.; Briggs, Andrew H.; Fayers, Peter; Ramsay, Craig R.; Norrie, John D.; Harvey, Ian M.; Buckley, Brian; Cook, Jonathan A. // PLoS Medicine;May2014, Vol. 11 Issue 5, p1 

    : Jonathan Cook and colleagues systematically reviewed the literature for methods of determining the target difference for use in calculating the necessary sample size for clinical trials, and discuss which methods are best for various types of trials. Please see later in the article for the...

  • Wanted: People to help advance medicine. Krol, Katharine // Indianapolis Business Journal;11/22/2004, Vol. 25 Issue 37, p13A 

    Addresses the issue of the slow enrollment in clinical trials in the United States. Reasons behind the lack of enrollees in clinical trials; Impact of the trend on medical research and public health; Steps that should be taken by medical research institutions and authorities to solve the low...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics